Opioid Use Disorder Market
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Opioid Use Disorder Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Buprenorphine
1.2.3 Methadone
1.2.4 Naltrexone
1.3 Market by Application
1.3.1 Global Opioid Use Disorder Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Moderate Pain Treatment
1.3.3 Severe Pain Treatment
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Opioid Use Disorder Market Perspective (2017-2028)
2.2 Opioid Use Disorder Growth Trends by Region
2.2.1 Opioid Use Disorder Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Opioid Use Disorder Historic Market Size by Region (2017-2022)
2.2.3 Opioid Use Disorder Forecasted Market Size by Region (2023-2028)
2.3 Opioid Use Disorder Market Dynamics
2.3.1 Opioid Use Disorder Industry Trends
2.3.2 Opioid Use Disorder Market Drivers
2.3.3 Opioid Use Disorder Market Challenges
2.3.4 Opioid Use Disorder Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Opioid Use Disorder Players by Revenue
3.1.1 Global Top Opioid Use Disorder Players by Revenue (2017-2022)
3.1.2 Global Opioid Use Disorder Revenue Market Share by Players (2017-2022)
3.2 Global Opioid Use Disorder Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Opioid Use Disorder Revenue
3.4 Global Opioid Use Disorder Market Concentration Ratio
3.4.1 Global Opioid Use Disorder Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Opioid Use Disorder Revenue in 2021
3.5 Opioid Use Disorder Key Players Head office and Area Served
3.6 Key Players Opioid Use Disorder Product Solution and Service
3.7 Date of Enter into Opioid Use Disorder Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Opioid Use Disorder Breakdown Data by Type
4.1 Global Opioid Use Disorder Historic Market Size by Type (2017-2022)
4.2 Global Opioid Use Disorder Forecasted Market Size by Type (2023-2028)
5 Opioid Use Disorder Breakdown Data by Application
5.1 Global Opioid Use Disorder Historic Market Size by Application (2017-2022)
5.2 Global Opioid Use Disorder Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Opioid Use Disorder Market Size (2017-2028)
6.2 North America Opioid Use Disorder Market Size by Country (2017-2022)
6.3 North America Opioid Use Disorder Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Opioid Use Disorder Market Size (2017-2028)
7.2 Europe Opioid Use Disorder Market Size by Country (2017-2022)
7.3 Europe Opioid Use Disorder Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Opioid Use Disorder Market Size (2017-2028)
8.2 Asia-Pacific Opioid Use Disorder Market Size by Country (2017-2022)
8.3 Asia-Pacific Opioid Use Disorder Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Opioid Use Disorder Market Size (2017-2028)
9.2 Latin America Opioid Use Disorder Market Size by Country (2017-2022)
9.3 Latin America Opioid Use Disorder Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Opioid Use Disorder Market Size (2017-2028)
10.2 Middle East & Africa Opioid Use Disorder Market Size by Country (2017-2022)
10.3 Middle East & Africa Opioid Use Disorder Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Indivior
11.1.1 Indivior Company Detail
11.1.2 Indivior Business Overview
11.1.3 Indivior Opioid Use Disorder Introduction
11.1.4 Indivior Revenue in Opioid Use Disorder Business (2017-2022)
11.1.5 Indivior Recent Development
11.2 Alkermes
11.2.1 Alkermes Company Detail
11.2.2 Alkermes Business Overview
11.2.3 Alkermes Opioid Use Disorder Introduction
11.2.4 Alkermes Revenue in Opioid Use Disorder Business (2017-2022)
11.2.5 Alkermes Recent Development
11.3 Titan Pharmaceuticals
11.3.1 Titan Pharmaceuticals Company Detail
11.3.2 Titan Pharmaceuticals Business Overview
11.3.3 Titan Pharmaceuticals Opioid Use Disorder Introduction
11.3.4 Titan Pharmaceuticals Revenue in Opioid Use Disorder Business (2017-2022)
11.3.5 Titan Pharmaceuticals Recent Development
11.4 Hikma Pharmaceuticals
11.4.1 Hikma Pharmaceuticals Company Detail
11.4.2 Hikma Pharmaceuticals Business Overview
11.4.3 Hikma Pharmaceuticals Opioid Use Disorder Introduction
11.4.4 Hikma Pharmaceuticals Revenue in Opioid Use Disorder Business (2017-2022)
11.4.5 Hikma Pharmaceuticals Recent Development
11.5 Teva Pharmaceuticals
11.5.1 Teva Pharmaceuticals Company Detail
11.5.2 Teva Pharmaceuticals Business Overview
11.5.3 Teva Pharmaceuticals Opioid Use Disorder Introduction
11.5.4 Teva Pharmaceuticals Revenue in Opioid Use Disorder Business (2017-2022)
11.5.5 Teva Pharmaceuticals Recent Development
11.6 MediciNova
11.6.1 MediciNova Company Detail
11.6.2 MediciNova Business Overview
11.6.3 MediciNova Opioid Use Disorder Introduction
11.6.4 MediciNova Revenue in Opioid Use Disorder Business (2017-2022)
11.6.5 MediciNova Recent Development
11.7 Orexo
11.7.1 Orexo Company Detail
11.7.2 Orexo Business Overview
11.7.3 Orexo Opioid Use Disorder Introduction
11.7.4 Orexo Revenue in Opioid Use Disorder Business (2017-2022)
11.7.5 Orexo Recent Development
11.8 Camurus
11.8.1 Camurus Company Detail
11.8.2 Camurus Business Overview
11.8.3 Camurus Opioid Use Disorder Introduction
11.8.4 Camurus Revenue in Opioid Use Disorder Business (2017-2022)
11.8.5 Camurus Recent Development
11.9 Omeros
11.9.1 Omeros Company Detail
11.9.2 Omeros Business Overview
11.9.3 Omeros Opioid Use Disorder Introduction
11.9.4 Omeros Revenue in Opioid Use Disorder Business (2017-2022)
11.9.5 Omeros Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Opioid Use Disorder Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Buprenorphine
Table 3. Key Players of Methadone
Table 4. Key Players of Naltrexone
Table 5. Global Opioid Use Disorder Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Opioid Use Disorder Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Opioid Use Disorder Market Size by Region (2017-2022) & (US$ Million)
Table 8. Global Opioid Use Disorder Market Share by Region (2017-2022)
Table 9. Global Opioid Use Disorder Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 10. Global Opioid Use Disorder Market Share by Region (2023-2028)
Table 11. Opioid Use Disorder Market Trends
Table 12. Opioid Use Disorder Market Drivers
Table 13. Opioid Use Disorder Market Challenges
Table 14. Opioid Use Disorder Market Restraints
Table 15. Global Opioid Use Disorder Revenue by Players (2017-2022) & (US$ Million)
Table 16. Global Opioid Use Disorder Market Share by Players (2017-2022)
Table 17. Global Top Opioid Use Disorder Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Opioid Use Disorder as of 2021)
Table 18. Ranking of Global Top Opioid Use Disorder Companies by Revenue (US$ Million) in 2021
Table 19. Global 5 Largest Players Market Share by Opioid Use Disorder Revenue (CR5 and HHI) & (2017-2022)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Opioid Use Disorder Product Solution and Service
Table 22. Date of Enter into Opioid Use Disorder Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Opioid Use Disorder Market Size by Type (2017-2022) & (US$ Million)
Table 25. Global Opioid Use Disorder Revenue Market Share by Type (2017-2022)
Table 26. Global Opioid Use Disorder Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 27. Global Opioid Use Disorder Revenue Market Share by Type (2023-2028)
Table 28. Global Opioid Use Disorder Market Size by Application (2017-2022) & (US$ Million)
Table 29. Global Opioid Use Disorder Revenue Market Share by Application (2017-2022)
Table 30. Global Opioid Use Disorder Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 31. Global Opioid Use Disorder Revenue Market Share by Application (2023-2028)
Table 32. North America Opioid Use Disorder Market Size by Country (2017-2022) & (US$ Million)
Table 33. North America Opioid Use Disorder Market Size by Country (2023-2028) & (US$ Million)
Table 34. Europe Opioid Use Disorder Market Size by Country (2017-2022) & (US$ Million)
Table 35. Europe Opioid Use Disorder Market Size by Country (2023-2028) & (US$ Million)
Table 36. Asia-Pacific Opioid Use Disorder Market Size by Region (2017-2022) & (US$ Million)
Table 37. Asia-Pacific Opioid Use Disorder Market Size by Region (2023-2028) & (US$ Million)
Table 38. Latin America Opioid Use Disorder Market Size by Country (2017-2022) & (US$ Million)
Table 39. Latin America Opioid Use Disorder Market Size by Country (2023-2028) & (US$ Million)
Table 40. Middle East & Africa Opioid Use Disorder Market Size by Country (2017-2022) & (US$ Million)
Table 41. Middle East & Africa Opioid Use Disorder Market Size by Country (2023-2028) & (US$ Million)
Table 42. Indivior Company Detail
Table 43. Indivior Business Overview
Table 44. Indivior Opioid Use Disorder Product
Table 45. Indivior Revenue in Opioid Use Disorder Business (2017-2022) & (US$ Million)
Table 46. Indivior Recent Development
Table 47. Alkermes Company Detail
Table 48. Alkermes Business Overview
Table 49. Alkermes Opioid Use Disorder Product
Table 50. Alkermes Revenue in Opioid Use Disorder Business (2017-2022) & (US$ Million)
Table 51. Alkermes Recent Development
Table 52. Titan Pharmaceuticals Company Detail
Table 53. Titan Pharmaceuticals Business Overview
Table 54. Titan Pharmaceuticals Opioid Use Disorder Product
Table 55. Titan Pharmaceuticals Revenue in Opioid Use Disorder Business (2017-2022) & (US$ Million)
Table 56. Titan Pharmaceuticals Recent Development
Table 57. Hikma Pharmaceuticals Company Detail
Table 58. Hikma Pharmaceuticals Business Overview
Table 59. Hikma Pharmaceuticals Opioid Use Disorder Product
Table 60. Hikma Pharmaceuticals Revenue in Opioid Use Disorder Business (2017-2022) & (US$ Million)
Table 61. Hikma Pharmaceuticals Recent Development
Table 62. Teva Pharmaceuticals Company Detail
Table 63. Teva Pharmaceuticals Business Overview
Table 64. Teva Pharmaceuticals Opioid Use Disorder Product
Table 65. Teva Pharmaceuticals Revenue in Opioid Use Disorder Business (2017-2022) & (US$ Million)
Table 66. Teva Pharmaceuticals Recent Development
Table 67. MediciNova Company Detail
Table 68. MediciNova Business Overview
Table 69. MediciNova Opioid Use Disorder Product
Table 70. MediciNova Revenue in Opioid Use Disorder Business (2017-2022) & (US$ Million)
Table 71. MediciNova Recent Development
Table 72. Orexo Company Detail
Table 73. Orexo Business Overview
Table 74. Orexo Opioid Use Disorder Product
Table 75. Orexo Revenue in Opioid Use Disorder Business (2017-2022) & (US$ Million)
Table 76. Orexo Recent Development
Table 77. Camurus Company Detail
Table 78. Camurus Business Overview
Table 79. Camurus Opioid Use Disorder Product
Table 80. Camurus Revenue in Opioid Use Disorder Business (2017-2022) & (US$ Million)
Table 81. Camurus Recent Development
Table 82. Omeros Company Detail
Table 83. Omeros Business Overview
Table 84. Omeros Opioid Use Disorder Product
Table 85. Omeros Revenue in Opioid Use Disorder Business (2017-2022) & (US$ Million)
Table 86. Omeros Recent Development
Table 87. Research Programs/Design for This Report
Table 88. Key Data Information from Secondary Sources
Table 89. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Opioid Use Disorder Market Share by Type: 2021 VS 2028
Figure 2. Buprenorphine Features
Figure 3. Methadone Features
Figure 4. Naltrexone Features
Figure 5. Global Opioid Use Disorder Market Share by Application in 2021 & 2028
Figure 6. Moderate Pain Treatment Case Studies
Figure 7. Severe Pain Treatment Case Studies
Figure 8. Opioid Use Disorder Report Years Considered
Figure 9. Global Opioid Use Disorder Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 10. Global Opioid Use Disorder Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Opioid Use Disorder Market Share by Region: 2021 VS 2028
Figure 12. Global Opioid Use Disorder Market Share by Players in 2021
Figure 13. Global Top Opioid Use Disorder Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Opioid Use Disorder as of 2021)
Figure 14. The Top 10 and 5 Players Market Share by Opioid Use Disorder Revenue in 2021
Figure 15. North America Opioid Use Disorder Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 16. North America Opioid Use Disorder Market Share by Country (2017-2028)
Figure 17. United States Opioid Use Disorder Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 18. Canada Opioid Use Disorder Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 19. Europe Opioid Use Disorder Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Europe Opioid Use Disorder Market Share by Country (2017-2028)
Figure 21. Germany Opioid Use Disorder Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. France Opioid Use Disorder Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. U.K. Opioid Use Disorder Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Italy Opioid Use Disorder Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Russia Opioid Use Disorder Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Nordic Countries Opioid Use Disorder Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Asia-Pacific Opioid Use Disorder Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Asia-Pacific Opioid Use Disorder Market Share by Region (2017-2028)
Figure 29. China Opioid Use Disorder Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Japan Opioid Use Disorder Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. South Korea Opioid Use Disorder Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Southeast Asia Opioid Use Disorder Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. India Opioid Use Disorder Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Australia Opioid Use Disorder Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Latin America Opioid Use Disorder Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Latin America Opioid Use Disorder Market Share by Country (2017-2028)
Figure 37. Mexico Opioid Use Disorder Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Brazil Opioid Use Disorder Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Middle East & Africa Opioid Use Disorder Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Middle East & Africa Opioid Use Disorder Market Share by Country (2017-2028)
Figure 41. Turkey Opioid Use Disorder Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Saudi Arabia Opioid Use Disorder Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Indivior Revenue Growth Rate in Opioid Use Disorder Business (2017-2022)
Figure 44. Alkermes Revenue Growth Rate in Opioid Use Disorder Business (2017-2022)
Figure 45. Titan Pharmaceuticals Revenue Growth Rate in Opioid Use Disorder Business (2017-2022)
Figure 46. Hikma Pharmaceuticals Revenue Growth Rate in Opioid Use Disorder Business (2017-2022)
Figure 47. Teva Pharmaceuticals Revenue Growth Rate in Opioid Use Disorder Business (2017-2022)
Figure 48. MediciNova Revenue Growth Rate in Opioid Use Disorder Business (2017-2022)
Figure 49. Orexo Revenue Growth Rate in Opioid Use Disorder Business (2017-2022)
Figure 50. Camurus Revenue Growth Rate in Opioid Use Disorder Business (2017-2022)
Figure 51. Omeros Revenue Growth Rate in Opioid Use Disorder Business (2017-2022)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed
Industry Market Size
